Sionna Therapeutics Files 8-K

Ticker: SION · Form: 8-K · Filed: Jun 4, 2025 · CIK: 2036042

Sentiment: neutral

Topics: regulatory-filing, corporate-information

TL;DR

Sionna Therapeutics filed a routine 8-K on June 4, 2025, confirming regulatory disclosures and exhibits.

AI Summary

Sionna Therapeutics, Inc. filed an 8-K on June 4, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The company, incorporated in Delaware, is located at 21 Hickory Drive, Suite 500, Waltham, MA 02451, with a business phone number of 617-819-2020. This filing does not appear to contain specific financial transaction details or material events beyond the standard reporting requirements.

Why It Matters

This 8-K filing indicates Sionna Therapeutics is meeting its regulatory reporting obligations. It provides updated corporate information and confirms the filing of required exhibits.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for regulatory compliance and does not disclose any new material events, financial performance, or strategic changes that would inherently increase risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Sionna Therapeutics, Inc.?

The primary purpose of this 8-K filing is to report information under Regulation FD Disclosure and to file Financial Statements and Exhibits, as indicated by the filing's item information.

When was this 8-K report filed by Sionna Therapeutics, Inc.?

This 8-K report was filed as of June 4, 2025.

What is Sionna Therapeutics, Inc.'s principal executive office address?

Sionna Therapeutics, Inc.'s principal executive offices are located at 21 Hickory Drive, Suite 500, Waltham, MA 02451.

In which state is Sionna Therapeutics, Inc. incorporated?

Sionna Therapeutics, Inc. is incorporated in Delaware.

What is the registrant's telephone number as listed in the filing?

The registrant's telephone number is 617-819-2020.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 4, 2025 regarding Sionna Therapeutics, Inc. (SION).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing